Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:probenecid
|
| gptkbp:approvedBy |
gptkb:FDA
1951 |
| gptkbp:ATCCode |
M04AA01
|
| gptkbp:CASNumber |
57-66-9
|
| gptkbp:chemicalFormula |
C13H19NO4S
|
| gptkbp:contraindication |
renal impairment
kidney stones |
| gptkbp:drugInteraction |
gptkb:antibiotic
gptkb:NSAIDs gptkb:methotrexate |
| gptkbp:eliminationHalfLife |
5-8 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Benemid
|
| gptkbp:increasesExcretionOf |
uric acid
|
| gptkbp:indication |
adjunct to penicillin therapy
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
uricosuric
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting headache rash |
| gptkbp:synonym |
Probenecid
|
| gptkbp:usedFor |
gout
hyperuricemia |
| gptkbp:bfsParent |
gptkb:probenecid
|
| gptkbp:bfsLayer |
7
|